Replacement of anti-PD-1 drugs with prolgolimab during treatment, safety and efficacy
Andabekov, Timur, Napolskaia, Elena, Rodina, Maria, Khlobystina, Alina, Gulo, Elizaveta
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
ALBI and APRI score as prognostic factors for predicting the FABIB complications after liver resection in metastatic colorectal cancer
Napolskaia, Elena, Andabekov, Timur, Sigua, Badri, Rodina, Maria, Khlobystina, Alina, Gulo, Elizaveta
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial
Cheng, Ying, Han, Liang, Wu, Lin, Chen, Jun, Sun, Hongmei, Wen, Guilan, Ji, Yinghua, Dvorkin, Mikhail, Shi, Jianhua, Pan, Zhijie, Shi, Jinsheng, Wang, Xicheng, Bai, Yuansong, Melkadze, Tamar, Pan, Yueyin, Min, Xuhong, Viguro, Maksym, Li, Xingya, Zhao, Yanqiu, Yang, Junquan, Makharadze, Tamta, Arkania, Ekaterine, Kang, Wenying, Wang, Qingyu, Zhu, Jun
Published in JAMA : the journal of the American Medical Association (27.09.2022)
Published in JAMA : the journal of the American Medical Association (27.09.2022)
Get full text
Journal Article
Final results of a phase II trial of prolgolimab with platinum-based therapy and bevacizumab in patients with advanced cervical cancer
Fogt, Sergey, Andabekov, Timur, Shamsutdinova, Yana, Dvorkin, Mikhail, Artamonova, Elena, Chistyakov, Valerii, Zukov, Ruslan, Moiseenko, Vladimir, Nechaeva, Marina, Odintsova, Svetlana, Fadeeva, Natalia, Kislov, Nikolai, Tantsyrev, Denis, Tjulandin, Sergei, Fomin, Eugeniy, Linkova, Iuliia, Zinkina-Orikhan, Arina, Shustova, Mariia, Zhukova, Lyudmila
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial
Oliveira, Mafalda, Pominchuk, Denys, Nowecki, Zbigniew, Hamilton, Erika, Kulyaba, Yaroslav, Andabekov, Timur, Hotko, Yevhen, Melkadze, Tamar, Nemsadze, Gia, Neven, Patrick, Vladimirov, Vladimir, Zamagni, Claudio, Denys, Hannelore, Forget, Frédéric, Horvath, Zsolt, Nesterova, Alfiya, Ajimi, Maxine, Kirova, Bistra, Klinowska, Teresa, Lindemann, Justin P O, Lissa, Delphine, Mathewson, Alastair, Morrow, Christopher J, Traugottova, Zuzana, van Zyl, Ruaan, Arkania, Ekaterine
Published in The lancet oncology (01.11.2024)
Published in The lancet oncology (01.11.2024)
Get full text
Journal Article
Enfortumab vedotin (EV) with pembrolizumab (P) versus chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC): Analysis of cisplatin (cis)-eligible population from EV-302/KEYNOTE-A39
Bedke, Jens, Van Der Heijden, Michiel Simon, Powles, Thomas, Valderrama, Begoña Pérez, Kikuchi, Eiji, Iyer, Gopa, Vulsteke, Christof, Swami, Umang, Castellano, Daniel, Sarwar, Naveed, Drakaki, Alexandra, Hoffman-Censits, Jean H., Arafat, Waddah, Andabekov, Timur, Li, Jian-Ri, Lu, Yi-Tsung, Yu, Xuesong, Shetty, Aditya, Homet Moreno, Blanca, Gupta, Shilpa
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Clinical activity of camizestrant, a next-generation SERD, versus fulvestrant in patients with a detectable ESR1 mutation: Exploratory analysis of the SERENA-2 phase 2 trial
Oliveira, Mafalda, Pominchuk, Denys, Hamilton, Erika P., Kulyaba, Yaroslav, Melkadze, Tamar, Neven, Patrick, Nemsadze, Gia, Andabekov, Timur, Semegen, Yuriy, Hotko, Yevhen, Zamagni, Claudio, Vladimirov, Vladimir, Bennett, Maxine, Ciardullo, Carmela, Klinowska, Teresa, Lindemann, Justin P O, McEwen, Robert, Morrow, Christopher J., Arkania, Ekaterine
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Abstract GS3-02: GS3-02 Camizestrant, a next generation oral SERD vs fulvestrant in post-menopausal women with advanced ER-positive HER2-negative breast cancer: Results of the randomized, multi-dose Phase 2 SERENA-2 trial
Oliveira, Mafalda, Pominchuck, Denys, Nowecki, Zbigniew, Hamilton, Erika, Kulyaba, Yaroslav, Andabekov, Timur, Hotko, Yevhen, Melkadze, Tamar, Nemsadze, Gia, Neven, Patrick, Semegen, Yuriy, Vladmirov, Vladmir, Zamagni, Claudio, Denys, Hannelore, Forget, Frederic, Horvath, Zsolt, Nesterova, Alfiya, Bennett, Maxine, Kirova, Bistra, Klinowska, Teresa, Lindemann, Justin, Lissa, Delphine, Mathewson, Alastair, Morrow, Christopher, Traugottova, Zuzana, Van Zyl, Ruaan, Arkania, Ekaterine
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
DNA SEPARATION PROCESS
ANDABEKOV TIMUR TURDEEVICH, EVTUSHENKO VLADIMIR IVANOVICH, SHKOL'NIK MIKHAIL IOSIFOVICH, KARELIN MIKHAIL IVANOVICH, KLOCHKOVA TAT'JANA GERMANOVNA
Year of Publication 10.04.2009
Get full text
Year of Publication 10.04.2009
Patent